Zomacton Shortage Update: What Patients Need to Know in 2026

If you've been searching for information about a Zomacton shortage, you're not the first patient to do so. Zomacton (somatropin) is a specialty biologic growth hormone made by Ferring Pharmaceuticals, and like many specialty injectables, it can be difficult to find at a standard retail pharmacy. But is Zomacton actually in a shortage? And what does that mean for your treatment?

Here is the most up-to-date information available as of 2026.

Is There an Active Zomacton Shortage in 2026?

As of 2026, Zomacton does not appear on the FDA's Drug Shortage Database as an active shortage. Ferring Pharmaceuticals has not issued a formal supply disruption notice that is publicly available. This is good news for patients who depend on Zomacton for growth hormone replacement therapy.

However — and this is important — not being on the FDA shortage list does not mean Zomacton is easy to walk in and pick up at your local pharmacy. Because Zomacton is a specialty-dispensed medication, it is not routinely stocked at retail pharmacies. Many patients mistake the specialty pharmacy access challenge for a shortage, when the reality is more about how the drug is distributed.

Why Do Patients Feel Like Zomacton Is Hard to Find?

There are several structural reasons that make accessing Zomacton feel like a shortage even when it technically isn't:

• Specialty pharmacy-only dispensing: Zomacton is a biologic that requires cold chain management, reconstitution, and high-cost billing infrastructure — all of which only specialty pharmacies are set up to handle.
• Prior authorization delays: Nearly every insurance plan requires PA for growth hormone therapy, and the approval process can take days to weeks, creating a perceived gap in supply.
• Formulary restrictions: Some insurance plans prefer other somatropin brands (like Norditropin or Omnitrope), requiring step therapy or medical exceptions before Zomacton is covered.
• Limited specialty pharmacy networks: Not all specialty pharmacies carry Zomacton, and some insurance plans restrict which specialty pharmacies are in-network.

How to Monitor Zomacton Availability

If you want to stay on top of Zomacton's availability status, here's how:

1. FDA Drug Shortages Database: Visit fda.gov/drugs/drug-safety-and-availability/drug-shortages to check whether Zomacton (or somatropin) appears on the current shortage list.
2. ASHP Drug Shortage Database: The American Society of Health-System Pharmacists (ASHP) maintains its own shortage tracking database at ashp.org, which is often more current than the FDA's.
3. Your specialty pharmacy: Call your specialty pharmacy directly and ask about current stock levels and expected delivery timelines for your next refill.
4. Ferring's support line (1-844-567-9501): Ferring's patient support team can advise you on current availability and direct you to pharmacies with supply.

What to Do If You're Having Trouble Getting Zomacton

If you're experiencing access issues with Zomacton, here are your immediate steps:

1. Contact your prescriber's office and explain the situation. They can often identify alternative pharmacies or submit urgent PA appeals.
2. Ask about switching to an alternative somatropin brand that may be more readily available through your insurance's specialty pharmacy network.
3. Use medfinder to locate pharmacies near you that currently have Zomacton. medfinder calls pharmacies on your behalf and texts you results — ideal for specialty medications where availability is unpredictable.
4. If cost is a barrier, enroll in Ferring's Patient Support Program (up to $6,000/year for eligible patients) or explore discount programs like SingleCare.

38,004+ patients found their medications in stock

38K+

Find Zomacton In Stock Today →

What About Other Growth Hormone Products — Are They in Shortage?

The broader somatropin market in the United States is generally stable in 2026. Major brands including Norditropin, Genotropin, Humatrope, Omnitrope, and Saizen have been available without active FDA shortage designations. This means that if your specific insurance plan makes Zomacton difficult to access, your prescriber has other options to consider.

Bottom Line for Patients in 2026

Zomacton is not in a formal national shortage as of 2026, but it remains a specialty pharmacy-only medication with access barriers that can feel like a shortage to patients who don't know the system. The most effective strategies are proactive: connect with your prescriber and specialty pharmacy early, understand your insurance plan's requirements, and use resources like Ferring's patient support team and medfinder to navigate any gaps.

If finding Zomacton continues to be a challenge, explore our guide on alternatives to Zomacton for options your prescriber may recommend.